NMDAR inhibition-independent antidepressant actions of ketamine metabolites is a research paper published in Carolina Digital Repository (University of North Carolina at Chapel Hill) (2020). On theSindex it has a DataRank of 0.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 5R21MH099345-02
An NMDA Glycine Site Antagonist for the Treatment of Major Depressive Disorder
National Institutes of Health
Grant: 5R01MH107615-05
Therapeutic Efficacy of Ketamine Metabolites for Depression Treatment
National Institutes of Health
Grant: 5R01MH086828-09
Stress, depression and effects of novel antidepressants on excitatory synapses
FWCI
0.00
Citation Percentile
0.3%
Fields of Study
Keywords
Sustainable Development Goals